Results 51 to 60 of about 785,500 (213)

Invasive intravascular aspergillosis leading to myocardial infarction

open access: yes, 2017
Cardiac dissemination of invasive aspergillosis is a rare, often a fatal consequence of systemic mycosis. We present a heart transplant patient who succumbed to drug resistant aspergillus pneumonia.
Heather Ross   +3 more
core   +1 more source

Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?

open access: yesHematology, Transfusion and Cell Therapy
Objective: To evaluate the accuracy of the galactomannan serum test in diagnosing oral invasive aspergillosis. Methods: This prospective observational study included oncohematological neutropenic patients with suspected invasive aspergillosis, but ...
Maria Júlia Pagliarone   +8 more
doaj   +1 more source

Aspergillosis Complicating Severe Coronavirus Disease

open access: yesEmerging Infectious Diseases, 2021
Aspergillosis complicating severe influenza infection has been increasingly detected worldwide. Recently, coronavirus disease–associated pulmonary aspergillosis (CAPA) has been detected through rapid reports, primarily from centers in Europe.
Kieren A. Marr   +6 more
doaj   +1 more source

Long‐term stability of sinus complication management

open access: yesPeriodontology 2000, EarlyView.
Abstract Maxillary sinus augmentation shows a low incidence of complications and high clinical success due to favorable biological conditions and typically transient issues. Most complications are intraoperative, such as Schneiderian membrane perforation or hemorrhage, and are often resolved immediately.
Pablo Galindo‐Moreno   +5 more
wiley   +1 more source

Invasive pulmonary aspergillosis in non-immunocompromised patients

open access: yes, 1991
Profound neutropenia is the most common predisposing feature in invasive aspergillosis.' Classically, patients receiving cytotoxic chemotherapy for acute haematological malignancy, recipients of organ transplants, and those on high doses of systemic
Nicklason, F.   +2 more
core   +1 more source

Aspergillus spondylodiscitis in a patient with liver cirrhosis and diabetes mellitus

open access: yesZdravniški Vestnik, 2014
Aspergillus osteomyelitis is a rare manifestation of invasive aspergillosis which accounts for 1.8% to 5.6% of all invasive aspergillosis forms. As other forms of invasive aspergillosis, it predominantly occurs in immunosupressed patients with well ...
Tereza Rojko   +4 more
doaj  

Invasive Fungal Infections in Heart Transplants: A 10‐Year, Single Centre Retrospective Cohort Study From Subtropical Australia

open access: yesTransplant Infectious Disease, EarlyView.
In this 10‐year retrospective cohort study of heart transplant recipients in subtropical Australia, we characterize the incidence and microbiological profile of invasive fungal infections, highlighting the underappreciated burden of late‐onset and non‐Aspergillus mold infections and the potential underdiagnosis of polymicrobial disease.
Angus Lane   +7 more
wiley   +1 more source

Intranasal Ectopic Tooth in an Adolescent With Unilateral Cleft Lip and Palate: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT A 14‐year‐old male with repaired cleft lip and palate presented with unilateral foul‐smelling nasal discharge, obstruction, and facial pain. CT identified an intranasal ectopic tooth with chronic sinusitis. Surgical removal using a Caldwell Luc approach resulted in symptom resolution.
Mikyas Befekadu Nigusse   +4 more
wiley   +1 more source

Fulminant invasive aspergillosis of the mediastinum in an immunocompetent host: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Invasive aspergillosis is a serious complication in immunocompromised patients. It is an opportunistic disease, which predominantly occurs in the lungs, although dissemination to virtually any organ is possible.
Shakoor Muhammad   +3 more
doaj   +1 more source

Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis

open access: yesHematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT In recent years the addition of the oral BCL2 inhibitor venetoclax to hypomethylating agents (HMAs) has emerged as the standard‐of‐care for patients with acute myeloid leukemia (AML) who are not fit for intensive chemotherapy, significantly improving survival and quality‐of‐life.
Mariarita Sciumè   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy